Back to Search Start Over

Supplementary Figure 1 from SHP2 Inhibition Overcomes RTK-Mediated Pathway Reactivation in KRAS-Mutant Tumors Treated with MEK Inhibitors

Authors :
Huai-Xiang Hao
Morvarid Mohseni
Giordano Caponigro
Peter S. Hammerman
Jeffrey A. Engelman
Susan E. Moody
Saskia M. Brachmann
Eusebio Manchado
Eric Billy
Anne Haberkorn
Malika Kazic-Legueux
Lukas Manuel Dunkl
Hongyun Wang
Roberto Velazquez
Chen Liu
Hengyu Lu
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

Schematic illustration of MEKi-induced MAPK pathway feedback activation, SHP099 dose-dependent reduction of p-MEK induction by MEKi, and MEKi-induced p-AKT levels.

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....ab33e010e3ab7eccd5822273f9c9b791
Full Text :
https://doi.org/10.1158/1535-7163.22506412